Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial
Eisen, Tim, Prof, Joensuu, Heikki, Prof, Nathan, Paul D, PhD, Harper, Peter G, FRCP, Wojtukiewicz, Marek Z, Prof, Nicholson, Steve, MD, Bahl, Amit, MD, Tomczak, Piotr, PhD, Pyrhonen, Seppo, Prof, Fife, Kate, MD, Bono, Petri, PhD, Boxall, Jane, RN, Wagner, Andrea, MD, Jeffers, Michael, PhD, Lin, Tiffany, PharmD, Quinn, David I, FRACP
Published in The lancet oncology (01.10.2012)
Published in The lancet oncology (01.10.2012)
Get full text
Journal Article